PIII Valuation
P3 Health Partners Inc
$
8.530
- Overview
- Forecast
- Valuation
- Earnings
PIII Relative Valuation
PIII's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PIII is overvalued; if below, it's undervalued.
Historical Valuation
P3 Health Partners Inc (PIII) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.01 is considered Undervalued compared with the five-year average of -5.97. The fair price of P3 Health Partners Inc (PIII) is between 108.54 to 261.51 according to relative valuation methord. Compared to the current price of 8.27 USD , P3 Health Partners Inc is Undervalued By 92.38%.
Relative Value
Fair Zone
108.54-261.51
Current Price：8.27
92.38%
Undervalued
-0.56
PE
1Y
3Y
5Y
Trailing
Forward
-6.28
EV/EBITDA
P3 Health Partners Inc. (PIII) has a current EV/EBITDA of -6.28. The 5-year average EV/EBITDA is -2.49. The thresholds are as follows: Strongly Undervalued below -175.28, Undervalued between -175.28 and -88.88, Fairly Valued between 83.91 and -88.88, Overvalued between 83.91 and 170.31, and Strongly Overvalued above 170.31. The current Forward EV/EBITDA of -6.28 falls within the Historic Trend Line -Fairly Valued range.
-1.98
EV/EBIT
P3 Health Partners Inc. (PIII) has a current EV/EBIT of -1.98. The 5-year average EV/EBIT is -4.01. The thresholds are as follows: Strongly Undervalued below -9.55, Undervalued between -9.55 and -6.78, Fairly Valued between -1.23 and -6.78, Overvalued between -1.23 and 1.54, and Strongly Overvalued above 1.54. The current Forward EV/EBIT of -1.98 falls within the Historic Trend Line -Fairly Valued range.
0.01
PS
P3 Health Partners Inc. (PIII) has a current PS of 0.01. The 5-year average PS is 0.19. The thresholds are as follows: Strongly Undervalued below -0.16, Undervalued between -0.16 and 0.01, Fairly Valued between 0.36 and 0.01, Overvalued between 0.36 and 0.53, and Strongly Overvalued above 0.53. The current Forward PS of 0.01 falls within the Historic Trend Line -Fairly Valued range.
-9.51
P/OCF
P3 Health Partners Inc. (PIII) has a current P/OCF of -9.51. The 5-year average P/OCF is -17.12. The thresholds are as follows: Strongly Undervalued below -114.19, Undervalued between -114.19 and -65.65, Fairly Valued between 31.42 and -65.65, Overvalued between 31.42 and 79.96, and Strongly Overvalued above 79.96. The current Forward P/OCF of -9.51 falls within the Historic Trend Line -Fairly Valued range.
-1.46
P/FCF
P3 Health Partners Inc. (PIII) has a current P/FCF of -1.46. The 5-year average P/FCF is -2.75. The thresholds are as follows: Strongly Undervalued below -15.76, Undervalued between -15.76 and -9.25, Fairly Valued between 3.75 and -9.25, Overvalued between 3.75 and 10.26, and Strongly Overvalued above 10.26. The current Forward P/FCF of -1.46 falls within the Historic Trend Line -Fairly Valued range.
P3 Health Partners Inc (PIII) has a current Price-to-Book (P/B) ratio of 0.34. Compared to its 3-year average P/B ratio of -2.60 , the current P/B ratio is approximately -113.00% higher. Relative to its 5-year average P/B ratio of -2.39, the current P/B ratio is about -114.17% higher. P3 Health Partners Inc (PIII) has a Forward Free Cash Flow (FCF) yield of approximately -571.14%. Compared to its 3-year average FCF yield of -136.54%, the current FCF yield is approximately 318.30% lower. Relative to its 5-year average FCF yield of -98.94% , the current FCF yield is about 477.24% lower.
0.34
P/B
Median3y
-2.60
Median5y
-2.39
-571.14
FCF Yield
Median3y
-136.54
Median5y
-98.94
Competitors Valuation Multiple
The average P/S ratio for PIII's competitors is 0.81, providing a benchmark for relative valuation. P3 Health Partners Inc Corp (PIII) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of -3.93%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of PIII decreased by 56.24% over the past 1 year. The primary factor behind the change was an decrease in Revenue Growth from 388.49M to 373.23M.
The secondary factor is the Margin Expansion, contributed -7.13%to the performance.
Overall, the performance of PIII in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is P3 Health Partners Inc (PIII) currently overvalued or undervalued?
P3 Health Partners Inc (PIII) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.01 is considered Undervalued compared with the five-year average of -5.97. The fair price of P3 Health Partners Inc (PIII) is between 108.54 to 261.51 according to relative valuation methord. Compared to the current price of 8.27 USD , P3 Health Partners Inc is Undervalued By 92.38% .
What is P3 Health Partners Inc (PIII) fair value?
How does PIII's valuation metrics compare to the industry average?
What is the current P/B ratio for P3 Health Partners Inc (PIII) as of Sep 03 2025?
What is the current FCF Yield for P3 Health Partners Inc (PIII) as of Sep 03 2025?
What is the current Forward P/E ratio for P3 Health Partners Inc (PIII) as of Sep 03 2025?